Candesartan CAS 139481-59-7 Ịdị ọcha> Ụlọ ọrụ 99.0% (HPLC)
Ruifu Chemical Supply Candesartan Cilexetil Intermediate na ịdị ọcha dị elu
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Intermediate Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Intermediate CAS 139481-44-0
Tril Candesartan Cilexetil CAS 170791-09-0
Aha Chemical | Candesartan |
Ụdị okwu | CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl] methyl] -1H-Benzimidazole-7-Carboxylic Acid;3-[[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl] methyl] -2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP adịghị ọcha G |
Nọmba CAS | 139481-59-7 |
Nọmba CAT | RF-PI1889 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C24H20N6O3 |
Ibu molekụla | 440.45 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ọcha ntụ ntụ |
njirimara-HPLC | Oge Njide Yiri Ọkọlọtọ |
njirimara-IR | Yiri Standard |
Ụzọ ịdị ọcha / nyocha | > 99.0% (HPLC) |
Ebe Na-agbaze | 183.0 ~ 185.0 ℃ |
Ọnwụ na ihicha | <0.50% |
Mmiri (KF) | <0.50% |
Ihe fọdụrụ na mgbanye | <0.50% |
Ọla dị arọ | <20ppm |
Ọdịghị ọcha nke Onwe Onye | <1.00% (HPLC) |
Mgbakọta adịghị ọcha | <1.00% (HPLC) |
Ntụgharị uche | n20/D 1.745~1.747 |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | API;Maka ọgwụgwọ ọbara mgbali elu |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
Candesartan (CAS: 139481-59-7) bụ onye na-anabata angiotensin II na IC50 nke 0.26 nM.Ebumnuche: egosiputara angiotensin II nnabata candesartan maka ọgwụgwọ ọbara mgbali elu.Candesartan Cilexetil bụ nke izizi kwadoro na GB na Apr 29, 1997, wee kwado ya na US Food and Drug Administration (FDA) na June 4, 1998, ma kwadoro ya na Pharmaceuticals and Medical Devices Agency of Japan (PMDA) na Mar 12, 1999. Ọ bụ AstraZeneca mepụtara ya, wee ree ya dị ka Atacand nke AstraZeneca na GB na US, wee were ya dị ka Blopress site Takeda na JP.Candesartan Cilexetil bụ angiotensin II receptor blocker (ARB), ọ na-egbochi vasoconstrictor na aldosterone mmetụta nzuzo nke angiotensin II site na nhọrọ nke igbochi njikọ nke angiotensin II na onye na-anabata AT1 n'ọtụtụ anụ ahụ, dị ka akwara na-adịghị mma na gland adrenal.A na-egosi Atacand maka ọgwụgwọ ọbara mgbali elu na ndị okenye na ụmụaka 1 ruo <17 afọ, nkụda mmụọ obi (NYHA klas II-IV) ma jiri ya belata ọnwụ obi na ọrịa obi na ụlọ ọgwụ.